FDA Inspection
Michelle Fanale, M.D.Michelle Fanale, M.D. – FDA Inspection, Jun 26, 2009
Record Details
This FDA Inspection record concerns Michelle Fanale, M.D., with an inspection on June 26, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Michelle Fanale, M.D.
- Inspection Date
- June 26, 2009
- Product Type
- Drugs
View Company Profile
ID · 2725c3e6-672a-42c1-9fb3-91ef3f0b8209
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 594520
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Michelle Fanale, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 6, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 29, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 23, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Michelle Fanale, M.D.
- FDA Inspection 998131 - 2016-12-06
- FDA Inspection 723637 - 2011-04-29
- FDA Inspection 716166 - 2011-03-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.